Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
SLC22A16 encodes a member of the organic zwitterion transporter protein family which transports carnitine. Additionally we are shipping SLC22A16 Antibodies (28) and many more products for this protein.
Showing 3 out of 3 products:
SLC22A16 DNA hypomethylation might be a compensation for DNA loss to maintain SLC22A16 elevation in GC. SLC22A16 might be a valuable prognostic marker in GC.
Allele C of ABCB1 and allele A of SLC22A16 tended to have a greater association with grade 3/4 febrile neutropenia.
Deletions in SLC22A16, a doxorubicin transporter, are associated with a failure to achieve event free survival in immunochemotherapy-treated diffuse large B-cell lymphoma.
findings may greatly contribute to the elucidation of the roles of the Oct and Myc proteins in osteoblast direct reprogramming. The results may also lead to establishment of novel regenerative therapy for various bone resorption diseases
Knockdown of CT2 reduced the growth and viability of acute myeloid leukemia cells with high expression of CT2 (OCI-AML2 and HL60), but not low expression. CT2 knockdown reduced basal oxygen consumption without a concomitant increase in glycolysis.
Both gene and protein expression of OCT6 were decreased in both CDDP-resistant lung cancer cell lines compared with their expression in their respective parental cells.
cytotoxic assays, stable transfectants of leukemic Jurkat cells overexpressing SLC22A16 cells became significantly more sensitive to doxorubicin
Variant alleles in the ABCB1, SLC22A16 and CYP2B6 genes are associated with response to AC therapy in the treatment of breast cancer.
that hCT2 can mediate bleomycin-A5 and polyamine uptake, and that the rate of bleomycin-A5 accumulation may account for the differential response to the drug in patients.
identification, expression and function of human CT2 as a carnitine transporter in testis mediating transport of l-carnitine
Flipts might have a role in carnitine transport, particularly in brain
Identification as a novel organic cation transporter preferentially expressed in hematopoietic cells and leukemias
may be possible to use progestins to increase the response of endometrioid endometrial carcinoma with SLC22A16 expression to adriamycin-based chemotherapeutic regimens
Exploratory study suggests that the c.146A>G variation could contribute to variations in the pharmacokinetics of doxorubicin and doxorubicinol in Asian breast cancer patients.
SLC22A16 was abundantly expressed in clear-cell adenocarcinomaof the ovary.
This gene encodes a member of the organic zwitterion transporter protein family which transports carnitine. The encoded protein has also been shown to transport anticancer drugs like bleomycin (PMID: 20037140) successful treatment has been correlated with the level of activity of this transporter in tumor cells.
, carnitine transporter 2
, flipt 2
, fly-like putative organic ion transporter 2
, fly-like putative transporter 2
, organic cation transporter 6
, organic cation transporter OKB1
, organic cation/carnitine transporter 6
, solute carrier family 22 (organic cation transporter), member 16
, solute carrier family 22 member 16
, Solute carrier family 22 member 16